PRLD icon

Prelude Therapeutics
PRLD

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $41M invested in Prelude Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$627K
2
+$558K
3
+$523K
4
Millennium Management
Millennium Management
New York
+$385K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$321K

Top Sellers

1
-$7.8M
2
-$1.91M
3
-$1.84M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$583K
5
Walleye Capital
Walleye Capital
New York
-$172K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$3.5K
53
$2K
54
$1.23K
55
$1.22K
56
$1.04K
57
$648
58
$638
59
$82
60
$64
61
$54
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4